Established in 2016 and headquartered in Oslo, Norway, Zelluna ASA specializes... Established in 2016 and headquartered in Oslo, Norway, Zelluna ASA specializes in the creation of T-cell receptor (TCR) cellular immunotherapy treatments aimed at combating solid tumors.